Skip to main content

Table 2 NSCLC distribution by histology

From: Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review

 

N = 173 (%)

Adenocarcinoma

91 (52)

Squamous cell

34 (20)

Poorly differentiated

17 (10)

Adeno-squamous

11 (6)

Non-small cell cancer

6 (3)

Large cell carcinoma

5 (3)

Carcinoma

5 (3)

Bronchoalveolar

2 (1)

Squamous cell-Small cell

1 (0.5)

Mucoepidermoid

1 (0.5)

  1. NSCLC: Non-small cell lung cancer.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us